Your Article Summary
Using Thrombophilia Testing to Determine Anticoagulation Duration in Pediatric Thrombosis is not Cost-Effective
The Journal of Pediatrics, 07/01/09
O'Brien SH et al. - Universal thrombophilia testing after a first episode of thrombosis is not cost-effective when used solely to determine anticoagulation duration. Therefore, a full panel of thrombophilia studies does not need to be an automatic response at the time of any deep venous thrombosis diagnoses.
Related Articles
Clotting, Immune System, and Venous Thrombosis in Lung Adenocarcinoma Patients: A Prospective Study
Cancer Investigation, 11/18/09
Relevance Score: 89%
C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
Circulation, 11/04/09
Relevance Score: 88%
Lateral Sinus Thrombosis in the Pediatric Population: Multiple Presentations for a Potentially Lethal Disease
Pediatric Emergency Care, 10/21/09
Relevance Score: 88%
Cerebral Venous Thrombosis: Diagnostic Accuracy of Combined, Dynamic and Static, Contrast-Enhanced 4D MR Venography
American Journal of Neuroradiology, 11/13/09
Relevance Score: 87%
Scapular Abscess, Septic Emboli, and Deep Vein Thrombosis in a Healthy Child Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Case Report
Pediatric Emergency Care, 10/29/09
Relevance Score: 87%
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Duodenum-Sparing Technique of Head Resection in Solid Pseudopapillary Tumor of the Pancreas in Children
European Journal of Pediatric Surgery, 12/19/09
Fetal Brain Hemodynamic Changes in Intrauterine Transfusion: Influence of Needle Puncture Site
Fetal Diagnosis and Therapy, 12/19/09
Initial testing of topotecan by the pediatric preclinical testing program
Pediatric Blood & Cancer, 12/18/09

See Latest Articles